EDElaine Dempsey

Elaine Dempsey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elaine Dempsey has a total of 220 co-authors. Here are the top co-authors by number of shared publications:

  • Aileen Schroeter

    Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland

    2 shared publications
  • Akira Sumiyoshi

    Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan

    2 shared publications
  • Alberto Lazari

    Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK

    2 shared publications
  • Alejandra Lopez-Castro

    Instituto de Neurobiología, Universidad Nacional Autónoma de México campus Juriquilla

    2 shared publications
  • Alejandro Rivera-Olvera

    Donders Institute for Brain, Behaviour, and Cognition, Radboud University, Nijmegen, The Netherlands

    2 shared publications
  • Aleksandra Bortel

    McConnell Brain Imaging Centre, McGill University, Montreal, Canada

    2 shared publications

Latest Publications

  • Open Access

    Author Correction: A consensus protocol for functional connectivity analysis in the rat brain

    by Joanes Grandjean, Gabriel Desrosiers-Gregoire, Cynthia Anckaerts, Diego Angeles-Valdez, Fadi Ayad, David A. Barrière, Ines Blockx, Aleksandra Bortel, Margaret Broadwater, Beatriz M. Cardoso, et al.


  • Top Cited Papers

    A consensus protocol for functional connectivity analysis in the rat brain

    by Joanes Grandjean, Gabriel Desrosiers-Gregoire, Cynthia Anckaerts, Diego Angeles-Valdez, Fadi Ayad, David A. Barrière, Ines Blockx, Aleksandra Bortel, Margaret Broadwater, Beatriz M. Cardoso, et al.

    Task-free functional connectivity in animal models provides an experimental framework to examine connectivity phenomena under controlled conditions and allows for comparisons with data modalities collected under invasive or terminal procedures. Currently, animal acquisitions are performed with varying protocols and analyses that hamper result comparison and integration. Here we introduce StandardRat, a consensus rat functional magnetic resonance imaging acquisition protocol tested across 20 centers. To develop this protocol with optimized acquisition and processing parameters, we initially aggregated 65 functional imaging datasets acquired from rats across 46 centers. We developed a reproducible pipeline for analyzing rat data acquired with diverse protocols and determined experimental and processing parameters associated with the robust detection of functional connectivity across centers. We show that the standardized protocol enhances biologically plausible functional connectivity patterns relative to previous acquisitions. The protocol and processing pipeline described here is openly shared with the neuroimaging community to promote interoperability and cooperation toward tackling the most important challenges in neuroscience.


  • Open Access

    The Traditional Chinese Medicine Houttuynia cordata Thunb decoction alters intestinal barrier function via an EGFR dependent MAPK (ERK1/2) signalling pathway

    by Jinfan Wang, Elaine Dempsey, Sinéad C. Corr, Wirginia Kukula-Koch, Astrid Sasse, Helen Sheridan


  • Open Access

    Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model

    by Namrata Iyer, Michelle A. Williams, Amy A. O’callaghan, Elaine Dempsey, Raul Cabrera-Rubio, Mathilde Raverdeau, Fiona Crispie, Paul D. Cotter, Sinéad C. Corr

    The use of probiotics such as Lactobacillus and Bifidobacterium spp. as a therapeutic against inflammatory bowel disease (IBD) is of significant interest. Lactobacillus salivarus strain UCC118TM is a commensal that has been shown to possess probiotic properties in vitro and anti-infective properties in vivo. However, the usefulness of UCC118 TM as a therapeutic against colitis remains unclear. This study investigates the probiotic potential of Lactobacillus salivarius, UCC118™ in a mouse model of colitis. DSS-induced colitis was coupled with pre-treatment or post-treatment with UCC118TM by daily oral gavage. In the pre-treatment model of colitis, UCC118TM reduced the severity of the disease in the early stages. Improvement in disease severity was coupled with an upregulation of tissue IL-10 levels and increased expression of macrophage M2 markers. This anti-inflammatory activity of UCC118TM was further confirmed in vitro, using a model of LPS-treated bone marrow-derived macrophages. Taken together, these results suggest that UCC118TM may promote the resolution of inflammation. This was supported in a mouse model of established DSS-induced colitis whereby UCC118TM treatment accelerated recovery, as evidenced by weight, stool, histological markers and the recovery of microbiome-associated dysbiosis with an increased abundance of beneficial commensal species. These results demonstrate the potential of Lactobacillus salivarius UCC118TM as a probiotic-based therapeutic strategy to promote health through the upregulation of anti-inflammatory IL-10 and protect against dysbiosis during IBD.